- Home
- NOTV vs XTNT Comparison
NOTV vs XTNT Comparison
Compare NOTV & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- XTNT
- Stock Information
- Founded
- NOTV 1974
- XTNT N/A
- Country
- NOTV United States
- XTNT United States
- Employees
- NOTV N/A
- XTNT N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NOTV Health Care
- XTNT Health Care
- Exchange
- NOTV Nasdaq
- XTNT Nasdaq
- Market Cap
- NOTV 62.5M
- XTNT 60.9M
- IPO Year
- NOTV 1997
- XTNT N/A
- Fundamental
- Price
- NOTV $2.12
- XTNT $0.55
- Analyst Decision
- NOTV Strong Buy
- XTNT
- Analyst Count
- NOTV 1
- XTNT 0
- Target Price
- NOTV $5.00
- XTNT N/A
- AVG Volume (30 Days)
- NOTV 385.1K
- XTNT 48.0K
- Earning Date
- NOTV 08-06-2025
- XTNT 08-12-2025
- Dividend Yield
- NOTV N/A
- XTNT N/A
- EPS Growth
- NOTV N/A
- XTNT N/A
- EPS
- NOTV N/A
- XTNT N/A
- Revenue
- NOTV $480,402,000.00
- XTNT $122,298,000.00
- Revenue This Year
- NOTV $4.99
- XTNT $12.68
- Revenue Next Year
- NOTV $5.39
- XTNT $5.40
- P/E Ratio
- NOTV N/A
- XTNT N/A
- Revenue Growth
- NOTV N/A
- XTNT 20.81
- 52 Week Low
- NOTV $1.15
- XTNT $0.33
- 52 Week High
- NOTV $6.48
- XTNT $0.78
- Technical
- Relative Strength Index (RSI)
- NOTV 52.04
- XTNT 36.49
- Support Level
- NOTV $1.86
- XTNT $0.54
- Resistance Level
- NOTV $2.15
- XTNT $0.66
- Average True Range (ATR)
- NOTV 0.19
- XTNT 0.03
- MACD
- NOTV 0.01
- XTNT -0.01
- Stochastic Oscillator
- NOTV 54.86
- XTNT 8.46
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.